Delhi High Court blocks Glenmark diabetes drugs

24-03-2015

The Delhi High Court has granted pharmaceutical company Merck an injunction that prevents Glenmark Pharmaceuticals from making and selling its diabetes drugs Zita (sitagliptin) and Zitamet (sitagliptin/metformin).


Merck Sharp & Dohme, Glenmark Pharmaceuticals, Zita, Januvia, Delhi High Court

LSIPR